Cooper Research Institute

Camden, New Jersey 08103

We've found

1 trials

at this facility

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Camden, NJ

Use our guide to learn which trials are right for you!